Even global pandemics can’t stop innovation in breast cancer diagnosis and treatment. Indeed, from virtual visits to new protocols, crises show us how adaptable we can be. Now it’s time to look forward to a new vision of our industry in the new normal.
Millions of women skipped their screening mammograms during the first few months of the pandemic, including nearly 1 million in the UK alone. Now we are seeing the consequences, with significantly higher numbers of breast cancers diagnosed at the advanced stage. One US provider, 21st Century Oncology, said 18 percent of women diagnosed at their 300 locations just through August had advanced disease compared to 12 percent in all of 2019.
In our Eighth Annual Breast Academy LIVE TV event November 6, leading breast imaging experts will talk about the future of breast screening and innovative ways to bring women back into the clinic, maximize workplace efficiency, and improve the quality of your exams.
In addition, we will hear about breast health and how state-of-the art technology, including contrast mammography and artificial intelligence, can help shape our new world.
Diagnostic accuracy matters more now than ever. In this part of the GE Healthcare Breast Academy program, you’ll learn why Contrast-Enhanced Spectral Mammography (CESM) is so important in this quest. Using iodinated contrast agent and dual-energy X-ray acquisition at low radiation dose, it can provide morphological images similar to standard digital mammograms along with contrast-enhanced images of abnormal vascular development and areas of unusual blood flow that may indicate the presence of tumors.
And, in a time when many centers are booking appointments months out and having to rethink workflow given COVID precautions, it enables you to conduct the exam in just 7 minutes in the same room as the screening mammogram with the same equipment and staff. “That’s a huge bonus,” said Catherine Lezy, GE Healthcare’s general manager of mammography.
The future of breast cancer, with or without the pandemic, was moving towards personalized screening, diagnostic evaluation, and treatment. During this section of the program, Artificial Intelligence (AI) in Breast Cancer Detection, our expert will explain why AI must be a part of that approach.
“There is no question that the pandemic has created challenges for us in terms of how we work,” said Lezy. “That’s why it is so important to hear from these experts who are reshaping the future of breast care.”
Our world has changed and there’s no going back. So join us on November 6 at 8 am ET for this three-hour, practice-changing webinar.
 Charity says nearly 1m women missed breast cancer check in pandemic. The Guardian. September 30. 2020. https://www.theguardian.com/society/2020/sep/30/charity-says-nearly-a-million-women-missed-breast-cancer-check
Covid-19 Outbreaks Led to Dangerous Delay in Cancer Diagnoses . Wall Street Journal. October 15, 2020. https://www.wsj.com/articles/covid-19-outbreaks-led-to-dangerous-delay-in-cancer-diagnoses-11602756013
 Daniaux et al. Arch Gynecol Obstet, 2015